Soleus Capital Management »

Nkarta shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Nkarta (NKTX) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Nkarta

Tip: Access up to 7 years of quarterly data

All positions including Nkarta held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkarta by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 300k 10.81

More positions owned by Soleus Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
United Therapeutics Corporation (UTHR)
Edap Tms S A Sponsored Adr (EDAP)
Iovance Biotherapeutics (IOVA)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tg Therapeutics (TGTX)
Celcuity (CELC)
Jasper Therapeutics Com New (JSPR)
Neuropace (NPCE)
Essa Pharma Com New (EPIX)
Organogenesis Hldgs (ORGO)
Axogen (AXGN)
Humana (HUM)
SurModics (SRDX)
Revolution Medicines (RVMD)

View all positions for Soleus Capital Management

Top funds holding Nkarta

RA Capital Management
Boxer Capital
Deerfield Management Company
Adage Capital Partners GP
Samsara BioCapital
NEA Management Company
Commodore Capital
BlackRock
EcoR1 Capital
Vanguard Group
T. Rowe Price Investment Management
Cormorant Asset Management
Sr One Capital Management
Superstring Capital Management
Daniel D. Thurber

View all funds holding Nkarta